Idenix Pharmaceuticals, Inc.
http://www.idenix.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Idenix Pharmaceuticals, Inc.
Deal Watch: Merck KGAA Teams With AI Biotechs On Drug Discovery Efforts
Plus deals involving Debiopharm/SunRock, RefleXion/3B Pharmaceuticals, Pharmanovia/Sanofi and more.
Deal Watch: Novartis, Ionis Team Up Again In Cardiovascular Disease
Plus deals involving ProQR/ Thea, Aeglea/Immedica, Ayala/Biolight, Quince/EryDel, ImmunoBiochem/ImmunoGen and GSK/LimmaTech, as well as deals in brief.
Gilead, Teva Document Disclosures Helped Sway Jury In Rare Pay-For-Delay Trial
Teva’s counsel notes a key factor in the jury's finding that Gilead’s patent settlement with Teva did not include a reverse payment to delay entry of Truvada and Atripla generics. A second trial will proceed on claims a collaboration agreement between Gilead and Janssen was anticompetitive.
Quality Street: India Needs A Frances Kelsey, Many Of Her Kind
Scrip delves into some of India’s critical compliance and quality challenges and efforts to address those.
Company Information
- Other Names / Subsidiaries
-
- Novirio Pharmaceuticals Limited
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice